Edgewise Therapeutics Inc...

NASDAQ: EWTX · Real-Time Price · USD
14.15
0.22 (1.58%)
At close: Aug 15, 2025, 3:59 PM
14.31
1.10%
After-hours: Aug 15, 2025, 05:00 PM EDT

Edgewise Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-150.7M -146.09M -133.81M -124.29M -115.88M -105.85M -100.16M -89.44M -81.22M -75.82M -67.64M -60.92M -56.37M -50.66M -42.81M -36.46M -27.15M -20.75M
Depreciation & Amortization
2.35M 2.32M 2.29M 2.19M 2.09M 2.02M 1.73M 1.29M 959K 652K 538K 524K 423K 320K 272K 244K 230K 224K
Stock-Based Compensation
31.41M 28.9M 24.71M 22.13M 19.81M 18.59M 17.56M 16.14M 14.76M 12.78M 10.92M 9.06M 7.44M 6.09M 4.4M 2.72M 1.24M 605K
Other Working Capital
361K 4.07M 8.59M 2.92M -1.41M -2.74M -1.47M 2.3M 4.18M 4.08M 4.04M -1.13M 1.37M -345K 1.98M 3.53M -26K 1.97M
Other Non-Cash Items
-9.97M -11.32M -12.54M -8.81M -10.13M -10.59M -9.52M -12.4M -7.71M -3.29M -543K 5.84M 7.92M 6.6M 6.45M 1.95M -42K 580K
Deferred Income Tax
n/a n/a n/a -3.3M -1.12M n/a n/a 3.3M 1.12M n/a n/a -4.63M -4.63M -4.63M -4.63M n/a n/a n/a
Change in Working Capital
2.13M 7.89M 10.33M 3.19M 1.65M -1.89M -1.56M 4.16M 5.22M 2.78M 4.09M -110K 930K 3.56M 4.63M 4.77M 1.94M 1.97M
Operating Cash Flow
-124.78M -118.3M -109.03M -108.9M -103.58M -97.72M -91.95M -76.94M -66.88M -62.89M -52.63M -50.23M -46.5M -40.02M -33.51M -28.73M -23.74M -17.95M
Capital Expenditures
-888K -1.06M -1.31M -1.2M -1.14M -1.67M -5.75M -8.88M -9.75M -9.54M -5.55M -2.33M -1.45M -975K -668K -589K -144K -256K
Cash Acquisitions
n/a n/a n/a -27.14K -51.02K -55.22K -108.63K -9.18K 39.68K 43.38K 96.79K 7.22M 7.2M 7.2M 7.2M n/a n/a n/a
Purchase of Investments
-494.44M -271.63M -477.06M -453.66M -493.01M -566.51M -255.87M -362.77M -346.09M -295.39M -292.39M -160.74M -134.11M -237.45M -288.2M -297.34M -255.98M -88.89M
Sales Maturities Of Investments
423.34M 400.24M 293.71M 276.27M 313.61M 353.72M 364.5M 371.95M 306.41M 252.01M 227.36M 182.21M 149.41M 92.36M 46.64M 17.4M 7.2M n/a
Other Investing Acitivies
n/a n/a n/a 27.14K 51.02K 55.22K 108.63K 9.18K -39.68K -43.38K 31.66M 24.53M -6.6M 598K -95.87M -112.85M -81.69M -88.89M
Investing Cash Flow
-71.98M 127.55M -184.66M -178.59M -180.54M -214.46M 102.89M 307K -49.43M -52.92M -70.58M 19.14M 13.85M -146.07M -242.23M -280.53M -248.92M -89.14M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a -35K n/a n/a n/a 35K n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
242.69M 242.04M 243.97M 2.29M 2.25M 2.66M 759K 475K 440K 250K 302K 510K 582K 403K 229K -64K 25.04M 25.18M
Financial Cash Flow
196.68M 10.4M 249.25M 299.35M 295.8M 294.22M 53.17M -159K 129.78M 129.59M 129.64M 130.27M 582K -493K 186.38M 281.09M 306.2M 307.23M
Net Cash Flow
-81K 19.66M -44.43M 11.85M 11.68M -17.97M 64.1M -76.79M 13.47M 13.78M 6.43M 99.18M -32.06M -186.58M -89.35M -28.16M 33.54M 200.13M
Free Cash Flow
-125.67M -119.36M -110.34M -110.1M -104.72M -99.39M -97.69M -85.81M -76.63M -72.43M -58.18M -52.57M -47.95M -41M -34.17M -29.32M -23.88M -18.21M